Cargando…

Adenosine metabolized from extracellular ATP promotes type 2 immunity through triggering A(2B)AR signaling in intestinal epithelial cells

Intestinal nematode parasites can cross the epithelial barrier, causing tissue damage and release of danger-associated molecular patterns (DAMPs) that may promote host protective type 2 immunity. We investigate whether adenosine binding to the A(2B) adenosine receptor (A(2B)AR) on intestinal epithel...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Naccache, Darine W., Chen, Fei, Palma, Mark J., Lemenze, Alexander, Fischer, Matthew A., Wu, Wenhui, Mishra, Pankaj K., Eltzschig, Holger K., Robson, Simon C., Di Virgilio, Francesco, Yap, George S., Edelblum, Karen L., Haskó, György, Gause, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402265/
https://www.ncbi.nlm.nih.gov/pubmed/35926464
http://dx.doi.org/10.1016/j.celrep.2022.111150
Descripción
Sumario:Intestinal nematode parasites can cross the epithelial barrier, causing tissue damage and release of danger-associated molecular patterns (DAMPs) that may promote host protective type 2 immunity. We investigate whether adenosine binding to the A(2B) adenosine receptor (A(2B)AR) on intestinal epithelial cells (IECs) plays an important role. Specific blockade of IEC A(2B)AR inhibits the host protective memory response to the enteric helminth, Heligmosomoides polygyrus bakeri (Hpb), including disruption of granuloma development at the host-parasite interface. Memory T cell development is blocked during the primary response, and transcriptional analyses reveal profound impairment of IEC activation. Extracellular ATP is visualized 24 h after inoculation and is shown in CD39-deficient mice to be critical for the adenosine production mediating the initiation of type 2 immunity. Our studies indicate a potent adenosine-mediated IEC pathway that, along with the tuft cell circuit, is critical for the activation of type 2 immunity.